Edition:
India

CareDx Inc (CDNA.OQ)

CDNA.OQ on NASDAQ Stock Exchange Global Market

12.49USD
19 Jul 2018
Change (% chg)

-- (--)
Prev Close
$12.49
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
190,927
52-wk High
$16.00
52-wk Low
$1.15

Chart for

About

CareDx, Inc. is a molecular diagnostics company. The Company is focused on the discovery, development and commercialization of clinically differentiated diagnostic surveillance solutions for transplant patients. The Company's commercialized testing solution, the AlloMap heart transplant molecular test (AlloMap), is a gene... (more)

Overall

Beta: --
Market Cap(Mil.): $126.68
Shares Outstanding(Mil.): 22.54
Dividend: --
Yield (%): --

Financials

BRIEF-Caredx Inc Enters Into A License And Commercialization Agreement With Illumina

* CAREDX INC - ON MAY 4, 2018, CO ENTERED INTO A LICENSE AND COMMERCIALIZATION AGREEMENT WITH ILLUMINA, INC - SEC FILING

09 May 2018

BRIEF-Caredx Enters Into A Credit Agreement And Guaranty - SEC Filing

* CAREDX SAYS ON APRIL 17 ENTERED INTO A CREDIT AGREEMENT AND GUARANTY - SEC FILING

18 Apr 2018

BRIEF-Caredx Launches Heartcare For Heart Transplant Recipients

* ANNOUNCED LAUNCH OF HEARTCARE, A COMPREHENSIVE REJECTION SURVEILLANCE SOLUTION FOR HEART TRANSPLANT RECIPIENTS Source text for Eikon: Further company coverage:

10 Apr 2018

BRIEF-CareDx Q4 Non-Gaap Loss Per Share $0.09

* FY2018 REVENUE VIEW $61.5 MILLION -- THOMSON REUTERS I/B/E/S

23 Mar 2018

BRIEF-Caredx - Entered Binding Commitment With Perceptive Advisors For Term Loan Of Between $15 Mln And $35 Mln

* CAREDX - ENTERED BINDING COMMITMENT WITH PERCEPTIVE ADVISORS FOR A TERM LOAN OF BETWEEN $15 MILLION AND $35 MILLION

01 Mar 2018

Competitors

Earnings vs. Estimates